Roger Strode Featured in Q&A on the Rise of Private Equity Investments in Cardiology

February 15, 2023 Cardiovascular Business

Foley & Lardner LLP Partner Roger Strode is featured in the Cardiovascular Business Q&A “What the rise of private equity investments in cardiology means for cardiologists and their patients.”

Strode explains the trend of recapitalization transactions in the health care space, what makes cardiology so appealing to investors right now, and the long-term strategy of and perspectives on these investments.

People

Roger D. Strode

Sectors

Health Care & Life Sciences

Practice Areas

Health Care

People

Roger D. Strode

rstrode@foley.com

Chicago 312.832.4565

Related News

View All Posts

August 8, 2025 In the News

Gregory Husisian and David Simon Uncover the High Stakes of Tariff Evasion

Foley & Lardner LLP partners Gregory Husisian and David Simon are featured for their insights on how the U.S. government is cracking down on tariff evaders in the Newsweek article, "America Is Making Billions From Catching 'Tariff Cheaters.'"

August 7, 2025 In the News

Kyle Faget Weighs in on Trump Pharma Tariffs

Foley & Lardner LLP partner Kyle Faget assessed the Trump administration's implementation of import tariffs on the pharmaceutical industry in the Pharma Life Sciences article, "Trump's pharma import tariffs threaten drug pricing, generics."

August 5, 2025 In the News

Aaron Maguregui on Health Data Sharing Plan – 'I would expect the FTC to be heavily involved'

Foley & Lardner LLP partner Aaron Maguregui addressed a new health care data sharing initiative announced by the federal government in the Bloomberg Law article, "Digital Data-Sharing Plan Tests Limits of Health Privacy Rules."